Search

Your search keyword '"Jamshidi, Hamid Reza"' showing total 110 results

Search Constraints

Start Over You searched for: Author "Jamshidi, Hamid Reza" Remove constraint Author: "Jamshidi, Hamid Reza"
110 results on '"Jamshidi, Hamid Reza"'

Search Results

3. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019

9. Optimization of Ventilation Therapy Prioritization Strategies among Patients with COVID-19: Lessons Learned from Real-World Data of nearly 600,000 Hospitalized Patients

11. Combining government, non-pharmaceutical interventions and vaccination in optimal control COVID-19.

15. Socioeconomic inequality in infant mortality in Iran and across its provinces

19. Iran in transition

22. Iran in transition

23. Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran

26. Evolution and Comparison Effects of Fludrocortisone and Betamethasone on Glucose and Lipid Profile in Rats.

27. Using drug sales data to evaluate the epidemiology of cardio-metabolic risk factors and their inequality: an ecological study on atorvastatin and total cholesterol in Iran

28. National and sub-national prevalence, trend, and burden of metabolic risk factors (MRFs) in Iran: 1990-2013, study protocol

29. Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy

31. Socioeconomic inequality in infant mortality in Iran and across its provinces

34. "Budget Impact Analyses": A Practical Policy Making Tool for Drug Reimbursement Decisions.

35. The Effect of Ziziphus Jujuba Fruit Extract in Diabetic and Non-Diabetic Rat.

36. Costs of Treatment after Renal Transplantation: Is it Worth to Pay More?

38. National and Subnational Patterns of Cause of Death in Iran 1990-2015: Applied Methods.

39. Burden of Cancers in Iran from 1990 to 2010: Findings from the Global Burden of Disease Study 2010.

40. Burden of Drug and Alcohol Use Disorders in Iran: findings from the Global Burden of Disease Study 2010.

41. The Most Prevalent Causes of Deaths, DALYs, and Geriatric Syndromes in Iranian Elderly People Between 1990 and 2010: findings from the Global Burden of Disease study 2010.

42. Tobacco Smoking Status and the Contribution to Burden of Diseases in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010.

43. Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010.

44. National and Sub-national Burden of Breast Cancer in Iran; 1990-2013.

45. National and Sub-national Prevalence, Trend, and Burden of End Stage Renal Diseases (ESRD) in Iran 1990-2013; The Study Protocol.

46. National and Sub-national Burden of Chronic Diseases Attributable to Lifestyle Risk Factors in Iran 1990 - 2013; Study Protocol.

47. National and Sub-national Trend and Burden of Injuries in Iran, 1990 - 2013: A Study Protocol.

48. NASBOD 2013: Design, Definitions, and Metrics.

49. Using drug sales data to evaluate the epidemiology of cardiometabolic risk factors and their inequality: an ecological study on atorvastatin and total cholesterol in Iran.

50. The Most Prevalent Causes of Deaths, DALYs, and Geriatric Syndromes in Iranian Elderly People Between 1990 and 2010: findings from the Global Burden of Disease study 2010.

Catalog

Books, media, physical & digital resources